Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Supernus Pharmaceuticals, Inc.”

68 pharma patents match "Supernus Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 68
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 68 pharmaceutical patents matching "Supernus Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

68 results for “Supernus Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 8470364

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  2. US 8394406

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  3. US 8394405

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  4. US 8298580

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  5. US 8298576

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  6. US 8211464

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  7. US 8206740

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted

  8. US 8193211

    Controlled release compositions of gamma-hydroxybutyrate

    Supernus Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  9. US 8017149

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  10. US 7910128

    Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

    Supernus Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  11. US 7910131

    Method of treating seizures using modified release formulations of oxcarbazepine

    Supernus Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  12. US 7781448

    Once daily dosage forms of trospium

    Supernus Pharmaceuticals, Inc. · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  13. US 7781449

    Trospium chloride treatment method

    Supernus Pharmaceuticals, Inc. · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  14. US 7763635

    Once daily dosage forms of trospium

    Supernus Pharmaceuticals, Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  15. US 7759359

    Method of treating bladder dysfunction with once-a-day trospium salt formulation

    Supernus Pharmaceuticals, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  16. US 7749532

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  17. US 7722898

    Modified-release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted

  18. US 7611728

    Osmotic delivery of therapeutic compounds by solubility enhancement

    Supernus Pharmaceuticals, Inc. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  19. US 7410978

    Once daily dosage forms of trospium

    Supernus Pharmaceuticals, Inc. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

  20. US 7259153

    Drug formulation and delivery using crystalline methylated cyclodextrins

    Supernus Pharmaceuticals, Inc. · Granted Aug 21, 2007 · Expires Aug 16, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.